BairaviShankarMD

Physician

Dr. Shankar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Johns Hopkins University School of MedicineClass of 2021
Rice UniversityBA, Anthropology, Biochemistry & Cell Biology, Cum Laude, 2013 - 2017

Honorable Mention-SKCCC Fellow Research Day Sidney Kimmel Comprehensive Cancer Center (SKCCC), 2020
Outstanding Major in Cultural Anthropology Rice University, Department of Anthropology, 2017
Second Prize - Social Science Rice Undergraduate Research Symposium, 2017
Second Prize - Neuroscience Rice Undergraduate Research Symposium, 2016
Join now to see all

PubMed

250 citations
Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer.
Bairavi Shankar, Jiajia Zhang, Abdul Rafeh Naqash, Patrick M. Forde, Josephine Feliciano
JAMA Oncology. 2020-12-01
268 citations
Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors.
Karthik Suresh, Khinh Ranh Voong, Bairavi Shankar, Patrick M. Forde, David S. Ettinger
Journal of Thoracic Oncology. 2018-12-01
105 citations
Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy
Karthik Suresh, Kevin J. Psoter, Khinh Ranh Voong, Bairavi Shankar, Patrick M. Forde
Journal of Thoracic Oncology. 2019-03-01

Journal Articles

Current and potential therapeutic strategies for transthyretin cardiac amyloidosis
Marcus Williams, Bairavi Shankar, Joban Vaishnav, Mark Ranek, Frontiers in Drug Discovery, 10/12/2022